Fiche du document
1 septembre 2019
- doi: 10.3390/antiox8090353
- issn: 2076-3921
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3390/antiox8090353
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/31480567
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2076-3921
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Programs/31003A_182105///
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Programs/C150045-174626///
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Programs/IZCOZ0-177070///
Ce document est lié à :
info:eu-repo/grantAgreement/OTHER//wiss Society for Endocrinology-Diabetology, 2014 Young Independent Investigator Award///
Ce document est lié à :
info:eu-repo/grantAgreement/FOUNDATION_LEENAARDS//2016 Fellowship for Academic Promotion in Clinical Medicine///
Ce document est lié à :
info:eu-repo/grantAgreement/OTHER//Union Européenne des Médecins Spécialistes (UEMS) Section of Endocrinology, 3E-Exchange in Endocrinology Expertise Fellowship///
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_11053F0104682
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Scientific research Science research Science--Research PapersCiter ce document
A. Paunkov et al., « A Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds. », Serveur académique Lausannois, ID : 10.3390/antiox8090353
Métriques
Partage / Export
Résumé
Nrf2 is a master transcriptional regulator of antioxidant and cytoprotective pathways. Currently in its third decade, research on Nrf2 has expanded to encompass not only basic but also clinical studies. In the present bibliometric review, we employed the VOSviewer tool to describe the existing Nrf2 literature landscape. As of July 2019, 11,931 papers on Nrf2 were listed in the "Web of Science" database, with more than 1000 new papers published each year. As expected, terms related to oxidative stress and antioxidant molecules occur very often in the Nrf2 literature throughout the years. Interestingly, there is also a gradual increase in the occurrence of terms related to diseases or to natural compounds, the most prominent being sulforaphane, curcumin, and resveratrol that modulate the Nrf2 pathway. Going beyond molecular biology/biochemistry and related fields, Nrf2 research has begun to spread into more clinical areas like endocrinology/metabolism, cardiology, and nephrology, likely reflecting an increased interest in clinical applications of Nrf2 pathway activators. China has become the most prolific producer of Nrf2 papers the last five years followed by the USA and Japan, a reverse pattern compared to the past. In conclusion, Nrf2 is the subject of a globally active research field that keeps growing and extends from bench to bedside.